Education
About Us
Working with TipRanks
Follow Us
Hinge Health, Inc. Class A (HNGE)
NYSE:HNGE
HNGE Stock Chart & Stats
$41.31
-$1.41(-3.71%)
At close: 4:00 PM EDT
$41.31
-$1.41(-3.71%)
Day’s Range― - ―
52-Week Range$30.08 - $62.18
Previous Close$36.79
Volume525.07K
Average Volume (3M)1.38M
Market Cap
$3.19B
Enterprise Value$3.05B
Total Cash (Recent Filing)$363.86M
Total Debt (Recent Filing)$8.04M
Price to Earnings (P/E)―
Beta1.46
Next Earnings
May 07, 2026EPS Estimate
0.38Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.49
Shares Outstanding37,919,155
10 Day Avg. Volume2,250,056
30 Day Avg. Volume1,380,708
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)9.72
Price to Sales (P/S)6.26
P/FCF Ratio21.54
Enterprise Value/Market Cap0.96
Enterprise Value/Revenue5.19
Enterprise Value/Gross Profit6.52
Enterprise Value/Ebitda-5.79
Forecast
1Y Price Target
$59.08Price Target Upside43.02% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
AI-driven Efficiency And MarginsAI-powered automation that reduces care team time and holds labor costs flat supports margin expansion and scalable profitability.
Earnings And GuidanceEarnings that beat expectations combined with management's stronger-than-expected outlook could prompt upward revisions to revenue and operating income estimates.
Product Differentiation And Sales MomentumHingeSelect's alignment of in-person and digital care and high competitive win rates support continued contract wins and client retention.
Bears Say
Customer Mix RiskA high proportion of small- and medium-sized customers could make it harder to sustain yield improvements compared with a larger-enterprise customer base.
Investor Sentiment And Sector RiskPersistent investor fears about AI disruption and a weak software market backdrop have pressured the stock and could prolong downside until sentiment improves.
Pricing And Revenue Per MemberA stable average selling price may limit upside from pricing changes and constrain potential gains in revenue per member.
Hinge Health, Inc. Class A News
HNGE FAQ
What was Hinge Health, Inc. Class A’s price range in the past 12 months?
Hinge Health, Inc. Class A lowest stock price was $30.08 and its highest was $62.18 in the past 12 months.
What is Hinge Health, Inc. Class A’s market cap?
Hinge Health, Inc. Class A’s market cap is $3.19B.
When is Hinge Health, Inc. Class A’s upcoming earnings report date?
Hinge Health, Inc. Class A’s upcoming earnings report date is May 07, 2026 which is in 73 days.
How were Hinge Health, Inc. Class A’s earnings last quarter?
Hinge Health, Inc. Class A released its earnings results on Feb 10, 2026. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.413 by $0.077.
Is Hinge Health, Inc. Class A overvalued?
According to Wall Street analysts Hinge Health, Inc. Class A’s price is currently Undervalued.
Does Hinge Health, Inc. Class A pay dividends?
Hinge Health, Inc. Class A does not currently pay dividends.
What is Hinge Health, Inc. Class A’s EPS estimate?
Hinge Health, Inc. Class A’s EPS estimate is 0.38.
How many shares outstanding does Hinge Health, Inc. Class A have?
Hinge Health, Inc. Class A has 37,919,155 shares outstanding.
What happened to Hinge Health, Inc. Class A’s price movement after its last earnings report?
Hinge Health, Inc. Class A reported an EPS of $0.49 in its last earnings report, beating expectations of $0.413. Following the earnings report the stock price went up 17.277%.
Which hedge fund is a major shareholder of Hinge Health, Inc. Class A?
Currently, no hedge funds are holding shares in HNGE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Hinge Health, Inc. Class A Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$59.08 (43.02% Upside)
$59.08 (43.02% Upside)
Blogger Sentiment
Bullish
HNGE Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 183.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $79.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 9.6%
Last 30 Days ▼ 9.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Fundamentals
Return on Equity
-106.91%
Trailing 12-Months
Asset Growth
10.26%
Trailing 12-Months
Company Description
Hinge Health, Inc. Class A
Hinge Health, Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation. It also provides various administrative and operations support services. The company was founded in 2012 and is headquartered in San Francisco, California.
HNGE Company Deck
HNGE Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized strong operational and financial momentum: robust revenue growth, high margins, exceptional free cash flow generation, meaningful AI-driven efficiency gains, high retention, and large commercial expansion (24.6M contracted lives). Management provided confident 2026 guidance while noting deliberate investments and conservatism (e.g., limited near-term revenue from Hinge Select and flat ASP assumptions). Key risks and watch items include slower guided growth in 2026 versus 2025, still-low engagement yield relative to long-term benchmarks, delayed monetization of Hinge Select, and potentially confusing buyback disclosures that reduced cash. Overall, positive execution and durability of the business were the dominant themes, with a few strategic and timing-related caveats to monitor.View all HNGE earnings summariesHNGE Stock 12 Month Forecast
Average Price Target
$59.08
▲(43.02% Upside)
Technical Analysis
Eterna Therapeutics
―
MSP Recovery
―
Bluejay Diagnostics
―
Tivic Health Systems
―
Heart Test Laboratories, Inc.
―
Ownership Overview
Currently, No data available
---